These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 19415165

  • 1. Quality of life and seizure control in patients with brain tumor-related epilepsy treated with levetiracetam monotherapy: preliminary data of an open-label study.
    Dinapoli L, Maschio M, Jandolo B, Fabi A, Pace A, Sperati F, Muti P.
    Neurol Sci; 2009 Aug; 30(4):353-9. PubMed ID: 19415165
    [Abstract] [Full Text] [Related]

  • 2. Quality of life, mood and seizure control in patients with brain tumor related epilepsy treated with lacosamide as add-on therapy: A prospective explorative study with a historical control group.
    Maschio M, Zarabla A, Maialetti A, Fabi A, Vidiri A, Villani V, Giannarelli D.
    Epilepsy Behav; 2017 Aug; 73():83-89. PubMed ID: 28623754
    [Abstract] [Full Text] [Related]

  • 3. Levetiracetam monotherapy in patients with brain tumor-related epilepsy: seizure control, safety, and quality of life.
    Maschio M, Dinapoli L, Sperati F, Pace A, Fabi A, Vidiri A, Muti P.
    J Neurooncol; 2011 Aug; 104(1):205-14. PubMed ID: 21107994
    [Abstract] [Full Text] [Related]

  • 4. An open-label study of levetiracetam at individualised doses between 1000 and 3000 mg day(-1) in adult patients with refractory epilepsy.
    Abou-Khalil B, Hemdal P, Privitera MD.
    Seizure; 2003 Apr; 12(3):141-9. PubMed ID: 12651078
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of pregabalin add-on treatment on seizure control, quality of life, and anxiety in patients with brain tumour-related epilepsy: a pilot study.
    Maschio M, Dinapoli L, Sperati F, Pace A, Fabi A, Vidiri A, Pompili A, Carapella CM.
    Epileptic Disord; 2012 Dec; 14(4):388-97. PubMed ID: 23248037
    [Abstract] [Full Text] [Related]

  • 7. Levetiracetam therapy in patients with brain tumour and epilepsy.
    Maschio M, Albani F, Baruzzi A, Zarabla A, Dinapoli L, Pace A, Pompili A, Carapella CM, Occhipinti E, Jandolo B.
    J Neurooncol; 2006 Oct; 80(1):97-100. PubMed ID: 16685465
    [Abstract] [Full Text] [Related]

  • 8. Levetiracetam and pregabalin for antiepileptic monotherapy in patients with primary brain tumors. A phase II randomized study.
    Rossetti AO, Jeckelmann S, Novy J, Roth P, Weller M, Stupp R.
    Neuro Oncol; 2014 Apr; 16(4):584-8. PubMed ID: 24311644
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Brand name to generic substitution of levetiracetam in patients with epilepsy.
    Gha-Hyun L, Dae SJ.
    Seizure; 2018 Aug; 60():127-131. PubMed ID: 29960217
    [Abstract] [Full Text] [Related]

  • 13. Levetiracetam monotherapy for elderly patients with epilepsy.
    Alsaadi TM, Koopmans S, Apperson M, Farias S.
    Seizure; 2004 Jan; 13(1):58-60. PubMed ID: 14741184
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Retrospective analysis of the efficacy and tolerability of levetiracetam in patients with metastatic brain tumors.
    Newton HB, Dalton J, Goldlust S, Pearl D.
    J Neurooncol; 2007 Sep; 84(3):293-6. PubMed ID: 17431542
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.